These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20568588)

  • 1. Bisphosphonates: do we know their role in adjuvant breast cancer treatment?
    Barginear MF; Van Poznak C
    Oncology (Williston Park); 2010 May; 24(6):475, 478, 480. PubMed ID: 20568588
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of bisphosphonates in the adjuvant setting for breast cancer.
    Reeder JG; Brufsky AM
    Oncology (Williston Park); 2010 May; 24(6):462-7, 475. PubMed ID: 20568587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer.
    Strobl S; Wimmer K; Exner R; Devyatko Y; Bolliger M; Fitzal F; Gnant M
    Curr Treat Options Oncol; 2018 Mar; 19(4):18. PubMed ID: 29527635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates may help men with osteoporosis.
    Harv Health Lett; 2013 Jan; 38(3):8. PubMed ID: 23556169
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
    Hadji P; Coleman RE; Wilson C; Powles TJ; Clézardin P; Aapro M; Costa L; Body JJ; Markopoulos C; Santini D; Diel I; Di Leo A; Cameron D; Dodwell D; Smith I; Gnant M; Gray R; Harbeck N; Thurlimann B; Untch M; Cortes J; Martin M; Albert US; Conte PF; Ejlertsen B; Bergh J; Kaufmann M; Holen I
    Ann Oncol; 2016 Mar; 27(3):379-90. PubMed ID: 26681681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?
    Amoroso V; Petrelli F; Pedersini R; Simoncini EL; Clézardin P; Barni S; Berruti A
    Future Oncol; 2015; 11(21):2853-6. PubMed ID: 26403833
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteoporosis treatment may benefit breast cancer patients.
    Kremer R
    Womens Health (Lond); 2015 Nov; 11(6):789-92. PubMed ID: 26541855
    [No Abstract]   [Full Text] [Related]  

  • 8. Are bisphosphonates ready for the adjuvant setting?
    Korde LA; Gralow JR
    Oncology (Williston Park); 2010 May; 24(6):480, 485. PubMed ID: 20568589
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of zoledronic acid in the treatment of breast cancer].
    Chen J; Liu ZY; Zhao LJ
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):318-9. PubMed ID: 21575510
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of Bisphosphonates in Breast Cancer Therapy.
    Goldvaser H; Amir E
    Curr Treat Options Oncol; 2019 Mar; 20(4):26. PubMed ID: 30874905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denosumab and the current status of bone-modifying drugs in breast cancer.
    Lee BL; Higgins MJ; Goss PE
    Acta Oncol; 2012 Feb; 51(2):157-67. PubMed ID: 22150116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis management in patients with breast cancer: EMAS position statement.
    Trémollieres FA; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; van der Schouw YT; Senturk LM; Simoncini T; Stevenson JC; Stute P; Rees M
    Maturitas; 2017 Jan; 95():65-71. PubMed ID: 27802892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Lipton A
    Breast Cancer Res Treat; 2010 Aug; 122(3):627-36. PubMed ID: 20490653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant bisphosphonates for early-stage breast cancer.
    Brufsky A
    Lancet Oncol; 2011 Jul; 12(7):610-1. PubMed ID: 21708345
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
    Ito K; Blinder VS; Elkin EB
    J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis.
    Morris GJ; Mitchell EP
    J Natl Med Assoc; 2007 Jan; 99(1):35-45. PubMed ID: 17304967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates in the adjuvant treatment of early breast cancer: conclusion.
    Eiermann W
    Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S16-7. PubMed ID: 20427028
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous bisphosphonates for breast cancer: impact on patient outcomes and scientific concepts.
    Gnant M
    Breast Dis; 2011; 33(2):71-81. PubMed ID: 22142663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates for breast cancer: questions answered, questions remaining.
    Layman R; Olson K; Van Poznak C
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):341-67. PubMed ID: 17512453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates and bone turnover in premenopausal women receiving adjuvant chemotherapy.
    Paterson A; Baker T
    J Clin Oncol; 2009 Mar; 27(7):1005-6. PubMed ID: 19171701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.